Mark Kendall, the guitarist for the legendary rock band Great White, first announced that he has been battling stage 4 kidney ...

The Great White guitarist, who announced his stage 4 kidney cancer diagnosis last year, revealed that his latest scans show ...

January 07, 2026-- NeuraLight, the leader in developing precision biomarkers for neurology, today announced the completion of PALOMA, a pioneering study comparing eye-movement measures with standard ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...

PALOMA study is one of the largest longitudinal studies using eye-movement biomarkers in patients with Parkinson’s diseaseNEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--NeuraLight, the leader in ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

Our thoughts are with the friends and family of Steve as well as all those who have lost a loved one on our latest list ...

Cytora Therapeutics Ltd. (Cytora), a clinical-stage biotechnology company based in Israel developing allogeneic, stem cell therapies; Made Scientific, Inc. (Made Scientific), a leading U.S.-based cell ...

Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

Former radio DJ Kim Johnston is suffering from symptoms like severe speech impairment, jaw instability and is dependent on a ...

Cell and gene therapies use the body's building blocks - cells and genetic material - to boost the immune system or correct ...